VIAL
Home/Directory/Compounding Pharmacy/CareFirst Specialty Pharmacy
Compounding Pharmacy
80/100

CareFirst Specialty Pharmacy

CareFirst Specialty Pharmacy is a Compounding Pharmacy evaluated by Vial against public federal and state records, with a Vial Score of 80/100 (Well Documented) as of Jun 30, 2026.

Well Documented
Confidence based on 7 of 8 checks shown · evaluated Jun 30, 2026

Public-record compliance signals only. Not a clinical assessment

Documented public record. No federal enforcement on file.

Compounding Pharmacy · Charlotte, NC

PCAB accredited

What we checked

Why this score: 7 of 8 checks complete. Each links to the public source it was verified against.

See all 8 checksHide checks

Federal & regulatory records

Clinical, pharmacy & commercial records

A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.

Vial describes the public record, not the provider. This is disclosure, not endorsement. Last reviewed June 30, 2026. See every source in the full report →

Correct your record

About CareFirst Specialty Pharmacy

Read moreShow less

CareFirst Specialty Pharmacy is a Compounding Pharmacy based in Charlotte, NC. It carries PCAB accreditation.

Services

What CareFirst Specialty Pharmacy offers

Based on publicly disclosed services and compounds.

Services, pricing & compounds
Primary Services
Compounding Pharmacy
  • ·Compounding Pharmacy
PCAB-accredited compounding
Pricing
Pricing not disclosed
  • ·No membership required
  • ·Insurance not accepted
Pricing not publicly disclosed. Confirm the all-in monthly cost with the provider.

Worth asking before you choose

Questions to put to CareFirst Specialty Pharmacy directly before you commit.

  1. 1Are you 503A or 503B registered, and can you provide proof of FDA establishment registration?
  2. 2Are you PCAB accredited, and what is your most recent inspection date?
  3. 3Can you provide a Certificate of Analysis (COA) for the compounded medications you dispense?

Screenshot these or show your doctor: they’re the same questions Vial would ask.

Frequently asked about CareFirst Specialty Pharmacy

Is CareFirst Specialty Pharmacy legitimate?

Vial does not certify providers as "legitimate." We evaluate CareFirst Specialty Pharmacy's public record across federal enforcement, registration, and disclosure signals. As of Jun 30, 2026, CareFirst Specialty Pharmacy has no active federal enforcement on file and a Vial Score of 80 out of 100. Review the full record before deciding.

How much does CareFirst Specialty Pharmacy cost?

CareFirst Specialty Pharmacy does not publicly disclose pricing. Ask for a full cost breakdown (consult, prescription, and shipping) before committing.

What pharmacy does CareFirst Specialty Pharmacy use?

CareFirst Specialty Pharmacy does not publicly name its pharmacy partner. Worth asking which pharmacy compounds and ships your medication, and whether it is independently accredited.

Alternatives

Alternatives to CareFirst Specialty Pharmacy

Other Compounding Pharmacy in Vial’s directory, with pricing and states served. Open a profile, or compare side by side.

Apothecary Pharma LLCCompounding PharmacyPricing not disclosedCompare side-by-side →
AnazaoHealthCompounding PharmacyPricing not disclosedCompare side-by-side →
See 2 more alternativesShow fewer
Want the receipts?

See the full report

The institutional version of this profile: every signal we evaluated, every federal source we checked, the Vial Score and Record Depth behind the score, and citation-ready evidence. Built for sharing, screenshotting, and reference.

See the full report →
Report ID · CAREFIRS-2026-07-01 · Updated daily
Are you this provider?Claim this listingDispute this profile
Methodology v4.0 · Independence · Zero conflicts of interest

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.

See the full report →